WO2025252463 - A MEDICAMENT DELIVERY ASSEMBLY
National phase entry is expected:
Publication Number
WO/2025/252463
Publication Date
11.12.2025
International Application No.
PCT/EP2025/063910
International Filing Date
21.05.2025
Title **
[English]
A MEDICAMENT DELIVERY ASSEMBLY
[French]
ENSEMBLE D'ADMINISTRATION DE MÉDICAMENT
Applicants **
SHL MEDICAL AG
Inventors
GURI HUNDERTMARK, Pau Bernat
WYLER, Samuel
Priority Data
24179938.6
04.06.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2095 | |
| EPO | Filing, Examination, Granting | 8346 | |
| Japan | Filing, Examination, Granting | 2154 | |
| South Korea | Filing, Examination, Granting | 2066 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,401
Contact Us
Abstract[English]
A medicament delivery assembly (1, 101) comprising: a package body (10, 110) having a rigid outer shell (11, 111) defining a hermetically sealed interior reservoir (12, 112); a medicament bag (20, 120) arranged inside the interior 5 reservoir (12, 112) forming an activation volume (30, 130) between the medicament bag (20, 120) and the package body (10, 110); a medicament delivery member (40, 140); a gas pressure port (50, 150) configured to provide the activation volume (30, 130) with a pressurized gas; and a manually operated pump (62, 64) configured to provide pressurized gas to 0 the activation volume (30, 130) via the gas pressure port (50, 150) for enabling the medicament bag (20, 120) to be compressed by the pressurized gas acting on the flexible outer shell (21, 121) of the medicament bag (20, 120) to expel the medicament via the medicament delivery member (40, 140).[French]
L'invention concerne un ensemble d'administration de médicament (1, 101) comprenant : un corps d'encapsulation (10, 110) ayant une enveloppe externe rigide (11, 111) définissant un réservoir intérieur hermétiquement scellé (12, 112) ; un sac de médicament (20, 120) disposé à l'intérieur du réservoir intérieur (12, 112), formant un volume d'activation (30, 130) entre le sac de médicament (20, 120) et le corps d'encapsulation (10, 110) ; un élément d'administration de médicament (40, 140) ; un orifice de pression de gaz (50, 150) conçu pour fournir un gaz sous pression au volume d'activation (30, 130) par l’intermédiaire de l'orifice de pression de gaz (50, 150) ; et une pompe actionnée manuellement (62, 64) configurée pour fournir un gaz sous pression au volume d'activation (30, 130) par l'intermédiaire de l'orifice de pression de gaz (50, 150) pour permettre que le sac de médicament (20, 120) soit comprimé par le gaz sous pression agissant sur l'enveloppe externe flexible (21, 121) du sac de médicament (20, 120) pour expulser le médicament par l'intermédiaire de l'élément d'administration de médicament (40, 140).